GEMCITABINE GLENMARK 1000MG VIAL 1000 Powder for injection 50ml Vial

Discover Gemcitabine Glenmark 1000mg Powder for Injection

Gemcitabine Glenmark 1000mg is a powerful anticancer medication classified as an antimetabolite.

It is widely used in the treatment of various types of cancer, including non-small cell lung cancer, pancreatic cancer, breast cancer, and ovarian cancer.

This medication works by interfering with the growth of cancer cells, which are eventually destroyed by the body.

As a critical component of chemotherapy regimens, Gemcitabine Glenmark helps to slow down or stop the progression of cancer, improving patient outcomes when administered under strict medical supervision.

Benefits of Use:

• Targets and inhibits the proliferation of various cancer cells.
• Effective in treating multiple cancer types, including non-small cell lung, pancreatic, breast, and ovarian cancers.
• May be used alone or in combination with other chemotherapeutic agents for enhanced efficacy.
• Helps to improve disease-free survival and overall survival rates in eligible patients.

How to Use:

Gemcitabine Glenmark 1000mg Powder for Injection must be administered by a qualified healthcare professional in a clinical setting.

1. The powder is reconstituted with an appropriate sterile diluent before administration.
2. It is typically administered as an intravenous (IV) infusion over 30 minutes.
3. Dosage and treatment schedule are determined by the physician based on the patient's specific cancer type, stage, body surface area, and overall health.
4. Regular monitoring of blood counts and kidney/liver function is essential during treatment.

Caution & Warnings:

• Gemcitabine Glenmark should only be administered by physicians experienced in cancer chemotherapy.
• Close monitoring for adverse reactions, especially myelosuppression (reduction in blood cell counts), is crucial.
• Patients should report any signs of infection, bleeding, or unusual bruising immediately.
• Use with extreme caution in patients with pre-existing renal or hepatic impairment.
• Not recommended for use during pregnancy or lactation due to potential harm to the fetus/infant. Effective contraception is advised for both male and female patients during and for a period after treatment.
• Avoid vaccination with live vaccines during Gemcitabine therapy.
• Keep out of reach of children.
• Store according to specified conditions and do not use if the solution appears discolored or contains particulate matter after reconstitution.

Ingredients:

• Active Ingredient: Gemcitabine Hydrochloride equivalent to 1000 mg Gemcitabine.
• Excipients: Pharmaceutical excipients Q.S.

Product Details:

• Form: Powder for injection.
• Strength: 1000 mg Gemcitabine.
• Package Type: Vial.
• Administration Route: Intravenous.
• Manufacturer: Glenmark Pharmaceuticals.